Market Overview

Quanterix to Speak at Wells Fargo Securities 2018 Healthcare Conference

Share:

Company also attending Citi's 13th Annual
Biotech Conference

Quanterix
Corporation
(NASDAQ:QTRX), a company digitizing biomarker analysis
with the goal of advancing the science of precision health, today
announced that Kevin Hrusovsky, Chief Executive Officer, President and
Chairman of Quanterix, will present at the Wells
Fargo Securities 2018 Healthcare Conference
on Thursday, Sept. 6,
2018 at 9:45 a.m., EDT at The Westin Copley Place in Boston, Mass.
Hrusovsky will also be attending Citi's 13th Annual Biotech
Conference on the same day at the Four Seasons Boston, where he is
scheduled to meet privately with leading healthcare investors.

To access the live webcast of Quanterix' presentation at the Wells Fargo
Securities 2018 Healthcare Conference, please visit the News & Events
page within the Investors section of the Quanterix website at www.quanterix.com.
Replays of the webcast will be available for 90 days following the
conference.

About Quanterix
Quanterix is a company that is digitizing
biomarker analysis with the goal of advancing the science of precision
health. The company's digital health solution, Simoa, has the potential
to change the way in which healthcare is provided today by giving
researchers the ability to closely examine the continuum from health to
disease through ultrasensitive detection of biomarkers and to accelerate
drug development and approval. Quanterix' technology is designed to
enable much earlier disease detection, better prognoses and enhanced
treatment methods to improve the quality of life and longevity of the
population for generations to come. The technology is currently being
used for research applications in several therapeutic areas, including
oncology, neurology, cardiology, immunology and infectious disease. The
company was established in 2007 and is located in Lexington,
Massachusetts. For additional information, please visit https://www.quanterix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Words
such as "may," "will," "expect," "plan," "anticipate," "estimate,"
"intend" and similar expressions (as well as other words or expressions
referencing future events, conditions or circumstances) are intended to
identify forward-looking statements. Forward-looking statements in this
news release include, but are not limited to Simoa's potential ability
to change the way in which healthcare is provided today, and are based
on Quanterix's expectations and assumptions as of the date of this press
release. Each of these forward-looking statements involves risks and
uncertainties. Factors that may cause Quanterix's actual results to
differ from those expressed or implied in the forward-looking statements
in this press release are discussed in Quanterix's filings with the U.S.
Securities and Exchange Commission, including the "Risk Factors"
sections contained therein. Except as required by law, Quanterix assumes
no obligation to update any forward-looking statements contained herein
to reflect any change in expectations, even as new information becomes
available.

View Comments and Join the Discussion!